Feds agree to buy 100 M doses of potential Pfizer vaccine
The U.S. will pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by Pfizer and its German partner BioNTech.Shares of...
The U.S. will pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by Pfizer and its German partner BioNTech.Shares of...